99 related articles for article (PubMed ID: 2787800)
1. Effects of growth hormone therapy on circadian osteocalcin rhythms in idiopathic short stature.
Markowitz ME; DiMartino-Nardi J; Gasparini F; Fishman K; Rosen JF; Saenger P
J Clin Endocrinol Metab; 1989 Aug; 69(2):420-5. PubMed ID: 2787800
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
3. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
4. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
[TBL] [Abstract][Full Text] [Related]
6. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children.
Nishiyama S; Ikuta M; Nakamura T; Tomoeda S; Matsuda I
J Clin Endocrinol Metab; 1992 Apr; 74(4):906-9. PubMed ID: 1548358
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
[TBL] [Abstract][Full Text] [Related]
8. 24-h profile of serum osteocalcin in growth hormone (GH) deficient patients with and without GH treatment.
Nielsen HK; Jørgensen JO; Brixen K; Møller N; Charles P; Christensen JS
Growth Regul; 1991 Dec; 1(4):153-9. PubMed ID: 1842347
[TBL] [Abstract][Full Text] [Related]
9. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy.
Kanzaki S; Hosoda K; Moriwake T; Tanaka H; Kubo T; Inoue M; Higuchi J; Yamaji T; Seino Y
J Clin Endocrinol Metab; 1992 Oct; 75(4):1104-9. PubMed ID: 1400878
[TBL] [Abstract][Full Text] [Related]
10. The circadian rhythm of serum osteocalcin concentrations: effects of 1,25 dihydroxyvitamin D administration.
Markowitz ME; Gundberg CM; Rosen JF
Calcif Tissue Int; 1987 Apr; 40(4):179-83. PubMed ID: 3107769
[TBL] [Abstract][Full Text] [Related]
11. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children.
Boguszewski M; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1995 Sep; 80(9):2599-606. PubMed ID: 7673401
[TBL] [Abstract][Full Text] [Related]
14. The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males.
Link K; Blizzard RM; Evans WS; Kaiser DL; Parker MW; Rogol AD
J Clin Endocrinol Metab; 1986 Jan; 62(1):159-64. PubMed ID: 3940264
[TBL] [Abstract][Full Text] [Related]
15. [Serum levels of intact molecular osteocalcin in children with growth hormone (GH) deficiency during GH therapy: an early predictor of GH therapy].
Seino Y; Kanzaki S; Kubo T; Hibi I; Tanaka T; Suwa S; Tachibana K; Okuno A; Niimi H; Tsuchiya Y
Nihon Naibunpi Gakkai Zasshi; 1994 Dec; 70(10):1063-74. PubMed ID: 7859886
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone secretory patterns in children with short stature.
Costin G; Kaufman FR
J Pediatr; 1987 Mar; 110(3):362-8. PubMed ID: 3819936
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
Bercu BB; Shulman D; Root AW; Spiliotis BE
J Clin Endocrinol Metab; 1986 Sep; 63(3):709-16. PubMed ID: 3525601
[TBL] [Abstract][Full Text] [Related]
18. The effect of growth hormone treatment on height in children with idiopathic short stature.
Jeong HR; Shim YS; Lee HS; Hwang JS
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
Blum WF; Crowe BJ; Quigley CA; Jung H; Cao D; Ross JL; Braun L; Rappold G;
J Clin Endocrinol Metab; 2007 Jan; 92(1):219-28. PubMed ID: 17047016
[TBL] [Abstract][Full Text] [Related]
20. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]